https://www.selleckchem.com/pr....oducts/PCI-24781.htm
abortus hypovirulent smooth strain A19. This candidate vaccine mitigated B. abortus infection and prevented severe tissue damage, thereby protecting against lethal challenge with A19. Overall, the results indicated that the bioconjugate vaccine elicited a strong immune response and provided significant protection against brucellosis. The described vaccine preparation strategy is safe and avoids large-scale culture of the highly pathogenic B. abortus.Hydrodynamic-based microfluidic platforms enable single-cell arraying and analysis ove
Like
Comment
Share
